Search Medical Condition
Please enter condition
Please choose location from dropdown
 

Tel Hashomer, Israel Clinical Trials

A listing of Tel Hashomer, Israel clinical trials actively recruiting patients volunteers.

RESULTS

Found (767) clinical trials

Preoperative Hexakapron Reduces Bleeding in Bariatric Surgery

Patients scheduled for primary laparoscopic sleeve gastrectomy for the treatment of morbid obesity will be assigned to receive tranexamic acid vs. placebo before surgery. Intraoperative bleeding will be scored, as well as postoperative bleeding and blood or blood-product requirements. POstoperative venous thromboembolic events will be recorded up to 2 months ...

Phase

0.0 miles

Learn More »

Fecal Microbiota Transplantation (FMT) in Metastatic Melanoma Patients Who Failed Immunotherapy

This is a phase I single-center study of fecal microbiota transplant (FMT) in melanoma patients who failed all standard lines of therapy. Eligible patients must have a disease amenable to biopsy and lack of contra-indications to FMT. Patients will undergo a baseline evaluation including imaging, tumor biopsy, blood samples and ...

Phase

0.0 miles

Learn More »

Treatment for Clostridium-difficile Infection With IMM529

Subjects who provide voluntary written informed consent will be screened for eligibility. Subjects meeting all of the inclusion and none of the exclusion criteria will be eligible to participate. Eligible subjects will be randomized up to 3 weeks post diagnosis of Clostridium-difficile Infection given SOC initiated already. Each subject will ...

Phase

0.0 miles

Learn More »

Lonquek for Autologous Stem Cell Mobilization

The aim of this study is to evaluate the efficacy and tolerability of Lonquek which is a pegylated (long-acting) version of Filgrastim recombinant human G-CSF (G-CSF) in mobilizing sufficient number of stem cells for autologous stem cell transplantation in patients with lymphoma and multiple myeloma.

Phase

0.0 miles

Learn More »

Trial of Inquiry Based Stress Reduction (IBSR) Program for BRCA1/2 Mutation Carriers

Primary goal: to evaluate the effectiveness of IBSR intervention on psychological well-being of BRCA carriers. Secondary goals: To understand the IBSR action mechanism and to develop a theoretical model. To examine the correlation between psychological well-being and optimism and health behaviors among carriers. To evaluate and define core beliefs related ...

Phase

0.0 miles

Learn More »

Exhaled Breath Biomarkers in Lung Cancer

Scientific background: Lung cancer is the most lethal cancer, responsible for 28% of cancer deaths and killing ~1.3 million people worldwide every year. Diagnosis and treatment of lung cancer in its early stages could increase the 5-year-survival rate 3-4 fold with a potential for cure4, 7. Therefore, the main goal ...

Phase N/A

0.0 miles

Learn More »

Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia

The purpose of the study is to determine the maximum tolerated dose and assess the safety, tolerability and activity of carfilzomib, alone and in combination with induction chemotherapy, in children with relapsed or refractory acute lymphoblastic leukemia (ALL).

Phase

0.0 miles

Learn More »

Corticosteroids+5-aminosalicylic Acid Compared to Corticosteroids in the Treatment of Moderate-severe Ulcerative Colitis

he role of steroids in the treatment of ulcerative Colitis (UC) is well established, and recommended by professional societies. However, there are no data investigating whether the addition and/or continuation of 5-aminosalicylic agents as combination therapy with systemic corticosteroids is superior to corticosteroids alone in patients with moderate-severe active UC. ...

Phase

0.0 miles

Learn More »

Thiotepa-based Conditioning for Allogeneic Stem-cell Transplantation (SCT) in Lymphoid Malignancies

The study hypotheses is that the introduction of dose escalated thiotepa, in substitution to busulfan or melphalan, will reduce toxicity after allogeneic transplantation while improving disease eradication in patients with lymphoid malignancies not eligible for standard transplantation.

Phase

0.0 miles

Learn More »

A Registry for BRCA Mutation Carriers With Pancreatic Ductal Adenocarcinoma

The purpose of this study is to better understand why pancreatic cancer develops in some people who are known carriers of the gene mutation (an abnormality) called BRCA, or its close relative PALB2. The investigators hope to do this by establishing a BRCA/PALB2 mutation carriers Pancreatic Ductal Adenocarcinoma (the common ...

Phase N/A

0.0 miles

Learn More »